Clinical Trial Update: A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases [Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Renal Cell Carcinoma

Drugs mentioned

• Cabometyx (cabozantinib) (cabozantinib)
• Opdivo (nivolumab) (nivolumab)
• Yervoy (Ipilimumab) (Ipilimumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Metastases, Renal Cell Carcinoma | Phase 2 | Status: RECRUITING